Načítá se...
Low-dose diethylstilbestrol for the treatment of advanced prostate cancer
OBJECTIVES: The purpose of this study was to assess the efficacy and safety of low-dose (1mg) daily diethylstilbestrol (DES) for the treatment of castrate-resistant prostate cancer (CRPC). METHODS AND MATERIALS: A retrospective chart review was performed on patients treated with low-dose DES who had...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3229833/ https://ncbi.nlm.nih.gov/pubmed/21795073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2010.12.004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|